go back

Tennessee rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $724,436 · 10th–90th $562,341–$1,698,2440%20%10th90th$724,436Professionalmedian $562,341 · 10th–90th $537,032–$616,5950%50%10th90th$562,341$500.0K$1.0M$2.0M$5.0M$10.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $724,435.96 / $1,698,243.65
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $562,341.33 / $616,595.00
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $562,341.33
Lucent Health
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,000,000.00 / $1,000,000.00 / $1,000,000.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $1,122,018.45
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $724,435.96